Diabetes Experts Affirm Importance of Self-Monitoring of Blood Glucose (SMBG) and Expanded Potential for Healthcare Professionals and their Patients Living with Diabetes BERLIN, Oct. 4, 2018 ...

People living with diabetes can now check, manage and share their blood sugar results as conveniently as they check everything else in their lives — wirelessly, on their iPhone, iPad or iPod touch.

MALVERN, Pa., Sept. 28, 2021 /PRNewswire/ -- LifeScan, a world leader in blood glucose monitoring, today announced findings from its Tu Salud (Your Health) clinical ...

The LifeScan unit of Johnson & Johnson is voluntarily recalling almost 2 million of its OneTouch Verio blood glucose meters because they malfunction at extremely high blood glucose levels, LifeScan ...

Diabetes Experts Affirm Importance of Self-Monitoring of Blood Glucose (SMBG) and Expanded Potential for Healthcare Professionals and their Patients Living with Diabetes BERLIN, Oct. 4, 2018 ...

The LifeScan OneTouch Verio IQ was recalled on March 25, 2013, because at extremely high blood glucose levels the meter will not warn the user of a high reading and will shut off. This could ...

MILPITAS, Calif. — LifeScan on Monday initiated a voluntary recall and replacement for all of its OneTouch VerioIQ blood-glucose meters in the United States, effective immediately. “Our patients’ ...

(Reuters) - Johnson & Johnson is recalling and replacing nearly 2 million meters used to measure blood glucose levels in diabetics due to a failure to operate properly at extremely high glucose ...

LifeScan, Inc. is initiating a voluntary recall and replacement for all of its OneTouch® Verio®IQ blood glucose meters in the United States, effective immediately. LifeScan is recalling and replacing ...

OneTouch VerioIQ System blood glucose monitor by LifeScan LifeScan issued a voluntary recall and replacement for all OneTouch Verio IQ blood glucose meters in the U.S. The product apparently shuts ...

"Research shows that ease of use remains a very important reason for meter selection by a majority of patients while, at the same time, one third say they can't make sense of their blood sugar results ...